| Literature DB >> 31195060 |
Daniel Wai-Hung Ho1, Yu-Man Tsui1, Karen Man-Fong Sze1, Lo-Kong Chan1, Tan-To Cheung2, Eva Lee1, Pak-Chung Sham3, Stephen Kwok-Wing Tsui4, Terence Kin-Wah Lee5, Irene Oi-Lin Ng6.
Abstract
Hepatocellular carcinoma (HCC) is heterogeneous, rendering its current curative treatments ineffective. The emergence of single-cell genomics represents a powerful strategy in delineating the complex molecular landscapes of cancers. In this study, we demonstrated the feasibility and merit of using single-cell RNA sequencing to dissect the intra-tumoral heterogeneity and analyze the single-cell transcriptomic landscape to detect rare cell subpopulations of significance. Exploration of the inter-relationship among liver cancer stem cell markers showed two distinct major cell populations according to EPCAM expression, and the EPCAM+ cells had upregulated expression of multiple oncogenes. We also identified a CD24+/CD44+-enriched cell subpopulation within the EPCAM+ cells which had specific signature genes and might indicate a novel stemness-related cell subclone in HCC. Notably, knockdown of signature gene CTSE for CD24+/CD44+ cells significantly reduced self-renewal ability on HCC cells in vitro and the stemness-related role of CTSE was further confirmed by in vivo tumorigenicity assays in nude mice. In summary, single-cell genomics is a useful tool to delineate HCC intratumoral heterogeneity at better resolution. It can identify rare but important cell subpopulations, and may guide better precision medicine in the long run.Entities:
Keywords: Cancer stem cell; Cancer stemness; HCC; Single-cell sequencing; Tumor heterogeneity
Mesh:
Substances:
Year: 2019 PMID: 31195060 DOI: 10.1016/j.canlet.2019.06.002
Source DB: PubMed Journal: Cancer Lett ISSN: 0304-3835 Impact factor: 8.679